← Leaderboards
Clayton E Mathews
University Of Florida
$19,414,489
Attributed
$36,809,286
Total exposure
17
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $8.5M · FY2006–25$10M$7.5M$5M$2.5M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$41,954,125 · 18
By mechanism
R01$12,542,059 · 4
U54$8,850,680 · 3
RM1$6,754,502 · 1
UC4$5,835,992 · 2
UH3$3,023,310 · 1
P01$2,409,311 · 3
Top collaborators
- Wei-Jun Qian14 shared
- Martha L Campbell-Thompson6 shared
- Rohit N. Kulkarni6 shared
- Ashutosh Agarwal5 shared
- Todd Michael Brusko5 shared
- Cherie L Stabler5 shared
- James Paul Carson4 shared
- Philip A Efron4 shared
Most similar at University Of Florida
Same institution · by research overlap
- Christopher E Forsmark$2,643,269
- Lyle L Moldawer$27,709,476
- Philip A Efron$8,666,844
- Paramita Chakrabarty$6,355,461
- Stefan Prokop$3,390,866
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsBeta CellIsletInsulin-Dependent Diabetes MellitusPancreasT-LymphocyteGenesImmuneComplexPlayInsulinProductionMediatingGeneticVariantProteinsTissuesCell PhysiologyDiabetes MellitusCytokinePhenotypeCohortSamplingSignal Transduction
Grant awards (57)
Dysfunctional Myelopoiesis and Myeloid-Derived Suppressor Cells in Sepsis Pathobiology$1,689,379
RM1 · FY2025 · GM
Discovery and Roles of In Situ Islet Neoantigens in Human Type 1 Diabetes$691,406
R01 · FY2025 · DK · contact PI
Project 2$336,004
P01 · FY2025 · AI · contact PI
Dysfunctional Myelopoiesis and Myeloid-Derived Suppressor Cells in Sepsis Pathobiology$1,689,645
RM1 · FY2024 · GM
Discovery and Roles of In Situ Islet Neoantigens in Human Type 1 Diabetes$696,346
R01 · FY2024 · DK · contact PI
Project 2$338,551
P01 · FY2024 · AI · contact PI
Engineering Human T Regulatory Cells with Chimeric Antigen Receptor Targeting NTPDase3 on the Surface of β cells for Type 1 Diabetes Control$300,000
R56 · FY2024 · AI
Multi-omic 3D tissue maps for a Human BioMolecular Atlas$1,947,288
U54 · FY2023 · DK
Dysfunctional Myelopoiesis and Myeloid-Derived Suppressor Cells in Sepsis Pathobiology$1,689,645
RM1 · FY2023 · GM
Organ Specific Project$1,587,501
U54 · FY2023 · DK · contact PI
Determining the mechanism of IFIH1 disease-associated variants on beta-cell and immune responses in Type 1 diabetes$1,192,518
R01 · FY2023 · DK
Engineering a Human Microphysiological System for the Characterization of Islet-Immune Interactions$994,468
UH3 · FY2023 · DK
Discovery and Roles of In Situ Islet Neoantigens in Human Type 1 Diabetes$715,709
R01 · FY2023 · DK · contact PI
Project 2$340,214
P01 · FY2023 · AI · contact PI
Dysfunctional Myelopoiesis and Myeloid-Derived Suppressor Cells in Sepsis Pathobiology$1,685,833
RM1 · FY2022 · GM
Multi-omic 3D tissue maps for a Human BioMolecular Atlas$1,211,401
U54 · FY2022 · DK
Determining the mechanism of IFIH1 disease-associated variants on beta-cell and immune responses in Type 1 diabetes$1,166,173
R01 · FY2022 · DK
Engineering a Human Microphysiological System for the Characterization of Islet-Immune Interactions$1,007,921
UH3 · FY2022 · DK
Organ Specific Project$888,101
U54 · FY2022 · DK · contact PI
Pathways and critical regulators of early beta-cell dysfunction in type 1 diabetes$732,134
R01 · FY2022 · DK
Project 1$278,370
P01 · FY2022 · AI · contact PI
Multi-omic 3D tissue maps for a Human BioMolecular Atlas$249,994
U54 · FY2022 · DK
Determining the mechanism of IFIH1 disease-associated variants on beta-cell and immune responses in Type 1 diabetes$1,166,173
R01 · FY2021 · DK
Engineering a Human Microphysiological System for the Characterization of Islet-Immune Interactions$1,020,921
UH3 · FY2021 · DK
Multi-omic 3D tissue maps for a Human BioMolecular Atlas$985,463
U54 · FY2021 · DK
Pathways and critical regulators of early beta-cell dysfunction in type 1 diabetes$740,135
R01 · FY2021 · DK
Organ Specific Project$702,096
U54 · FY2021 · DK · contact PI
Project 1$278,370
P01 · FY2021 · AI · contact PI
Determining the mechanism of IFIH1 disease-associated variants on beta-cell and immune responses in Type 1 diabetes$1,190,423
R01 · FY2020 · DK
Engineering a Human Microphysiological System for the Characterization of Islet-Immune Interactions$1,024,766
UG3 · FY2020 · DK
Multi-omic 3D tissue maps for a Human BioMolecular Atlas$750,693
U54 · FY2020 · DK
Pathways and critical regulators of early beta-cell dysfunction in type 1 diabetes$744,819
R01 · FY2020 · DK
Organ Specific Project$528,143
U54 · FY2020 · DK · contact PI
Project 1$277,268
P01 · FY2020 · AI · contact PI
Engineering a Human Microphysiological System for the Characterization of Islet-Immune Interactions$1,054,449
UG3 · FY2019 · DK
Pathways and critical regulators of early beta-cell dysfunction in type 1 diabetes$749,353
R01 · FY2019 · DK
Project 1$278,409
P01 · FY2019 · AI · contact PI
Project 1$282,125
P01 · FY2018 · AI · contact PI
Regulatory Networks and Biomarkers of Beta-cell Dysfunction and Apoptosis$98,016
UC4 · FY2016 · DK
mt-Nd2 and Resistance to Autoimmune Diabetes$314,300
R01 · FY2015 · DK · contact PI
Genetic Regulation of Human Beta Cell Destruction$3,116,568
UC4 · FY2014 · DK · contact PI
Regulatory Networks and Biomarkers of Beta-cell Dysfunction and Apoptosis$2,621,408
UC4 · FY2014 · DK
mt-Nd2 and Resistance to Autoimmune Diabetes$314,300
R01 · FY2014 · DK · contact PI
mt-Nd2 and Resistance to Autoimmune Diabetes$303,300
R01 · FY2013 · DK · contact PI
mt-Nd2 and Resistance to Autoimmune Diabetes$314,300
R01 · FY2012 · DK · contact PI
mt-Nd2 and resistance to autoimmune diabetes$106,913
R56 · FY2011 · DK · contact PI
mt-Nd2 and Resistance to Autoimmune Diabetes$255,323
R01 · FY2010 · DK · contact PI
mt-Nd2 and Resistance to Autoimmune Diabetes$113,146
R01 · FY2010 · DK · contact PI
mt-Nd2 and Resistance to Autoimmune Diabetes$305,919
R01 · FY2009 · DK · contact PI
mt-Nd2 and Resistance to Autoimmune Diabetes$1,465
R01 · FY2009 · DK · contact PI
mt-Nd2 and Resistance to Autoimmune Diabetes$257,902
R01 · FY2008 · DK · contact PI
mt-Nd2 and Resistance to Autoimmune Diabetes$46,618
R01 · FY2008 · DK · contact PI
mt-Nd2 and Resistance to Autoimmune Diabetes$152,902
R01 · FY2007 · DK · contact PI
mt-Nd2 and Resistance to Autoimmune Diabetes$111,920
R01 · FY2007 · DK · contact PI
mt-Nd2 and Resistance to Autoimmune Diabetes$265,475
R01 · FY2006 · DK · contact PI
MECHANISMS OF SUSCEPTIBILITY TO ALLOXAN IN MICE$14,627
F32 · FY2001 · DK
MECHANISMS OF SUSCEPTIBILITY TO ALLOXAN IN MICE$37,516
F32 · FY2000 · DK